CD8A and autoimmune disease: Existing datasets also tend to have limited resolution, for example, measuring mixtures of cells (e.g., whole blood or PBMCs) across only a few time-points, whereas assessment of CD8+ T cell transcriptomes, as demonstrated by a recent study, enabled autoimmune disease-activity prognosis beyond that achievable via measuring the transcriptomes of whole blood or PBMCs [86].